LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine

被引:6
作者
Baldi, Simona
Frascerra, Silvia
Ferrannini, Ele
Natali, Andrea
机构
[1] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Pisa, Sch Med, CNR, Inst Clin Physiol, I-56100 Pisa, Italy
关键词
LDL oxidation; lag phase; HDL oxidation; anti-oxidants;
D O I
10.1016/j.cca.2006.12.019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although LDL resistance to copper-induced oxidation is a time-honoured method, how it is modulated by the physiologic variability of lipid phenotype and what influences the protective action of homologous HDL and exogenous alanine is still unclear. Methods: In 159 subjects without severe dyslipidemias, LDL resistance to copper-induced oxidation (lag phase) was measured under standardised conditions, with alanine and with autologous HDL. Results: Lag phase was normally distributed and averaged 68 +/- 10 min (range: 40-105 min). Both VLDL-triglycerides (37 +/- 5, 52 +/- 7, 59 +/- 7, 53 +/- 5 mg/dl, p<0.05) and LDL-triglycerides (27 +/- 2, 27 +/- 1, 30 +/- 2, 35 +/- 3 mg/dl, p<0.01) increased across quartiles of lag phase. The relative LDL enrichment in triglycerides (triglycerides percent or triglycerides/cholesterol ratio) was strongly related to lag phase (r=0.29 and r=0.31, p<0.0005 for both) independently of age, gender, BMI, and presence of diabetes or hypertension. The protective effect of HDL was variable (+42 +/- 18 min) and largely dependent on the capacity of HDL to resist oxidation (r=0.69,p<0.0001). Alanine induced a rather constant lag phase prolongation (+32 +/- 7 min) that was weakly related only to baseline lag phase (r=0.17,p<0.05). Conclusions: Relative triglyceride abundance protects LDL from ex-vivo oxidation, HDL particles protect LDL mainly through substrate dilution and alanine probably through a direct anti-oxidant effect. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 29 条
[1]  
Abdel-Maksoud Madiha F, 2002, Semin Vasc Med, V2, P325, DOI 10.1055/s-2002-35403
[2]   Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans [J].
Balkan, J ;
Kanbagli, Ö ;
Mehmetçik, G ;
Mutlu-Türkoglu, Ü ;
Aykaç-Toker, G ;
Uysal, W .
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2002, 72 (05) :315-320
[3]   Effect of infusion of a triacylglycerol emulsion on low-density lipoprotein composition and oxidizability [J].
Callow, J ;
Samra, JS ;
Frayn, KN .
ATHEROSCLEROSIS, 1998, 137 (01) :115-123
[4]   Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers [J].
Carantoni, M ;
Abbasi, F ;
Warmerdam, F ;
Klebanov, M ;
Wang, PW ;
Chen, YDI ;
Azhar, S ;
Reaven, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :762-767
[5]   SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B [J].
CHAIT, A ;
BRAZG, RL ;
TRIBBLE, DL ;
KRAUSS, RM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :350-356
[6]   High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians [J].
Cherubini, A ;
Zuliani, G ;
Costantini, F ;
Pierdomenico, SD ;
Volpato, S ;
Mezzetti, A ;
Mecocci, P ;
Pezzuto, S ;
Bregnocchi, M ;
Fellin, R ;
Senin, U .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (05) :651-654
[7]   PREDISPOSITION TO LDL OXIDATION DURING COPPER-CATALYZED OXIDATIVE MODIFICATION AND ITS RELATION TO ALPHA-TOCOPHEROL CONTENT IN HUMANS [J].
COMINACINI, L ;
GARBIN, U ;
CENCI, B ;
DAVOLI, A ;
PASINI, C ;
RATTI, E ;
GAVIRAGHI, G ;
LOCASCIO, V ;
PASTORINO, AM .
CLINICA CHIMICA ACTA, 1991, 204 (1-3) :57-68
[8]   The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding [J].
de Man, FHAF ;
de Beer, F ;
van der Laarse, A ;
Jansen, H ;
Leuven, JAG ;
Souverijn, JHM ;
Vroom, TFFP ;
Schoormans, SCM ;
Fruchart, JC ;
Havekes, LM ;
Smelt, AHM .
ATHEROSCLEROSIS, 2000, 153 (02) :363-371
[9]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[10]  
GRUNDY SM, 1993, CLIN CARDIOL S, V16, P13